Home › Trial NCT02577926
The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia
- Trial IDNCT02577926
- StatusActive Not Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorRWTH Aachen University
- Enrollment207
- Start date2015-10
- ConditionsPolycythemia Vera (PV) · Essential Thrombocythemia (ET)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.